Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1079.57	-673.64	57.11
Graham Fair Price	4.96	37.62	35.85
PEG	48.30	1.28	-0.86
Price/Book	4.67	1.78	1.70
Price/Cash Flow	459.17	66.20	11.84
Prices/Earnings	-1.35	11.97	12.14
Price/Sales	173.77	5.90	2.15
Price/FCF	459.17	66.20	11.84
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	295.99	0.16	0.04
ROA	7.61	< 0.005	< 0.005
ROE	0.04	0.04	6.10
ROIC	0.02	0.03	31.66
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.52	0.41	27.87
Dividends QOQ	0.15	-0.10	-32.72
EBIT QOQ	-0.37	0.54	47.09
EPS QOQ	-0.14	0.09	-33.48
FCF QOQ	0.83	-0.81	-2.13
Revenue QOQ	121.51	-0.61	-99.50
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	11.67	0.00	inf
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.36	0.21	-41.76
Quick Ratio	6.20	0.09	-98.61
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	40.38	41.15	1.90
Cash	47.07	19.29	-59.02
Capex	-0.03	-0.08	-175.00
Free Cash Flow	5.80	1.11	-80.93
Revenue	31.89	12.42	-61.04
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.20	0.06	-98.98
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.85	27.39	860.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating